Banu Arun
The University of Texas MD Anderson Cancer Center · 703 works · 24,667 citations · h-index 76
Top works
- Significantly Higher Pathologic Complete Remission Rate After Neoadjuvant Therapy With Trastuzumab, Paclitaxel, and Epirubicin Chemotherapy: Results of a Randomized Trial in Human Epidermal Growth Factor Receptor 2–Positive Operable Breast Cancer
- Phase II Study of Weekly Docetaxel and Trastuzumab for Patients With HER-2–Overexpressing Metastatic Breast Cancer
- Gene Expression Profiles Predict Complete Pathologic Response to Neoadjuvant Paclitaxel and Fluorouracil, Doxorubicin, and Cyclophosphamide Chemotherapy in Breast Cancer
- American Society of Clinical Oncology Policy Statement Update: Genetic and Genomic Testing for Cancer Susceptibility
- Association analysis identifies 65 new breast cancer risk loci
- Gene expression profiles obtained from fine-needle aspirations of breast cancer reliably identify routine prognostic markers and reveal large-scale molecular differences between estrogen-negative and estrogen-positive tumors.
- Clinical and Pathologic Characteristics of Patients With BRCA-Positive and BRCA-Negative Breast Cancer
- Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer
- Incidence and Outcome of BRCA Mutations in Unselected Patients with Triple Receptor-Negative Breast Cancer
- American Society of Clinical Oncology Clinical Practice Guideline Update on the Use of Pharmacologic Interventions Including Tamoxifen, Raloxifene, and Aromatase Inhibition for Breast Cancer Risk Reduction
- PARP Inhibitor Upregulates PD-L1 Expression and Enhances Cancer-Associated Immunosuppression
- Association of Type and Location ofBRCA1andBRCA2Mutations With Risk of Breast and Ovarian Cancer
- Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk
- Residual Risk of Breast Cancer Recurrence 5 Years After Adjuvant Therapy
- Cancers associated with BRCA 1 and BRCA 2 mutations other than breast and ovarian
- The role of COX-2 inhibition in breast cancer treatment and prevention
- Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer
- Molecular prognostic factors for breast cancer metastasis and survival
- Ductal Carcinoma in Situ: State of the Science and Roadmap to Advance the Field
- Changes in plasma levels of inflammatory cytokines in response to paclitaxel chemotherapy